OXFORD, England, July 15 /PRNewswire/ --
- Senior Executives at Pfizer, Johnson & Johnson, GlaxoSmithKline, and Other Big Pharma use New Media to Bring Fresh Exchange
PharmaTelevision, the authoritative channel for the pharmaceutical, biotechnology and related industries, announced today the launch of its new service, PharmaTelevision Premium Content. PTV Premium Content will include PTV News - a daily news and analysis service to be launched in August. Subscription to the service will be free until 30 September, 2009. Dr Fintan Walton, CEO of PharmaVentures - the company behind PharmaTelevision - said, "Television captures and delivers something unique, recognising that business is ultimately about the people in it - whether it's a part of deal making, or discovery and development, or about a company's ability to finance itself. It's not a surprise to us that PharmaTelevision has become 'must view' TV for many senior executives and managers".
Dr Walton continues, "Launch of this new service means we can deliver to our subscribers great television programming and integrated news and analysis information services." PharmaTelevision addresses the current issues and future predictions of the industry, including those of the top companies, through news, analysis, interviews, panels and discussions. Interviewees come from companies such as Johnson & Johnson, Merck & Co., sanofi-aventis, Genzyme, MerckSerono, NICE UK, and Roche. As well as PTV News, current programmes include PharmaVentures Business Review; The Regional Report; The Financial Report; and PharmaDeals(R) Commentaries, and bring the major industry players straight to desktops - on demand from the viewer.
Dr Walton says, "This year, development to PharmaTelevision has been rapid as we meet the demand from our discerning audience. Our subscribers can look forward to significant upgrades that help them uncover further value in the service, and not least will shortly see news services compiled jointly by top experts from both the pharmaceutical and the television world. Subscribers to PharmaTelevision Premium Content can access over 200 high quality interviews and panel discussions filmed since June 2006. Dr Walton concludes, "It's an exciting time for us and our viewers."
PharmaTelevision (http://www.pharmatelevision.com) is the groundbreaking online TV channel for the pharmaceutical and biotech sector, offering insight, featured interviews, panel discussions and company information. Since May 2006, PharmaTelevision has rapidly grown and the channel now boasts over 200 TV programmes with a truly global audience, 60% of whom are C-suite executives. In 2008, the channel launched a sleek new look and introduced two exciting TV programmes - the Financial Report and the Regional Report, which, together with our well-established TV programmes, help to give our viewers a complete overview of industry trends, analysis including deals, investments and strategic policies within the sector. In 2009, PharmaTelevision will be launching PTV News - a daily summary and analysis of the major news headlines, ensuring that, wherever in the world they are, our audience can stay truly informed.
Testimonials about the value of PharmaTelevision from industry leading figures can be viewed online at http://www.pharmatelevision.com/VideoHandler.aspx?ID=166&Type=flv
A promotional Video about PharmaTelevision can be viewed online at: http://www.pharmatelevision.com/VideoHandler.aspx?ID=270
PharmaTelevision is a part of the business media division of PharmaVentures Ltd (http://www.pharmaventures.com).
Notes to Editors:
A leading results driven organisation, PharmaVentures ( http://www.pharmaventures.com) assists pharmaceutical and biotechnology companies across the world in all aspects of deal making and business intelligence. The Company's provides tailored consulting and transaction advisory services to the Life Science industry, with additional deal making support provided through the PharmaDeals range of intelligence products that include analysis tools and reports. An innovative business, PharmaVentures additionally provides industry insight through the world's first dedicated online pharmaceutical television channel http://www.pharmatelevision.com.
Now in its 17th year PharmaVentures is based in Oxford, UK, employs over 50 people mostly educated to PhD or above, and has increased its turnover five fold with 80% of revenues from outside the UK. With offices in the USA and Australia, the Company works for a variety of clients from start-ups to global corporate pharmaceutical companies.
For further information, or to receive a demonstration of the new service, please contact:
Lisa Holloway Marketing, PharmaTelevision +44-(0)1865-784-177 email@example.com Fintan Walton, +44-(0)1865-784-187 firstname.lastname@example.org
Copyright©2009 PR Newswire.
All rights reserved